Department of Medicine, Solna
The Department of Medicine, Solna is one of the largest departments at Karolinska Institutet. The core activities of the Department of Medicine are clinical and undergraduate education for medical as well as biomedical students, post-graduate education including at present 200 registered PhD students, and research in different areas of biomedicine.
Webinar
Karolinska Institutet Discovers med Elizabeth Arkema
Assistant Professor Elizabeth Arkema, Department of Medicine Solna
Presents an online webinar on the 7th of April, 12.00-13.00
Titel: Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study, European Respiratory Journal, September 2020.
Research groups
Research groups
Research group leaders and their research area.
Education
Education
Department of Medicine, Solna has courses for students in the Medical program, Biomedicine and Medical Informatics. The department conducts research training in several fields of research within the field of medical science. Currently, we have about 200 students.
Divisions
Divisions
The Department of Medicine consists of 43 research groups belonging to 12 different research Divisions representing a broad variety of medical entities.
Research
Research
The research at the department is extensive. The research activities at the Department of Medicine of the Karolinska University Hospital in Solna are executed in 41 research groups within 15 research units, covering most areas within the field of medicine. The three main profiles in research are:
Allergy
Cardiovascular medicine
Inflammatory diseases
Centre
Centre for Gender Medicine
Centre for Gender Medicine
Supporting research and education towards innovation in health care via promotion and implementation of sex and gender analysis.
Centre for Pharmacoepidemiology
Centre for Pharmacoepidemiology
The Centre for Pharmacoepidemiology (CPE) was established in 2005, with the explicit purpose to create a centre of academic excellence in pharmacoepidemiology, to meet the demands from stakeholders in society and industry for expertise and consultation in this field. The centre, which is still evolving, has since its start met the growing demands, both nationally and internationally, for data on drug safety, drug utilization and rational drug use, including pharmacogenetics. Read more about CPE here.